Serum KL‐6 in adult patients with polymyositis and dermatomyositis

Authors:

Abstract
Objective. To determine the serum levels of KL‐6, a mucin‐like high‐molecular‐weight glycoprotein, in polymyositis/dermatomyositis (PM/DM) patients. Methods. Serum samples from 42 adult PM/DM patients and 38 healthy control subjects were examined using specific enzyme‐linked immunosorbent assay (ELISA) systems. Results. The serum levels of KL‐6 in the PM/DM patients were significantly higher than those of the healthy controls. The elevated serum KL‐6 levels correlated with the presence of interstitial lung disease (ILD) and decreased percentage diffusing capacity of carbon monoxide (%DLco) in the PM/DM patients. The serum KL‐6 levels inversely correlated with %DLco and percentage vital capacity. Additionally, the serum KL‐6 levels were elevated in five of the seven DM patients with malignant neoplasia. Conclusions. These results suggest that the serum KL‐6 level might be a useful serum marker for ILD and internal malignancy in PM/DM.